Prpic V, Basavappa S, Liddle R A, Mangel A W
Department of Medicine, Duke University Medical Center, Durham, NC.
Biochem Biophys Res Commun. 1994 Jun 30;201(3):1483-9. doi: 10.1006/bbrc.1994.1871.
The release of cholecystokinin was investigated in STC-1 cells, an intestinal cholecystokinin-secreting cell line. Fifteen minute incubation of cells with the amino acid, L-phenylalanine (20 mM), or the phosphodiesterase inhibitor, IBMX (100 microM), stimulated cholecystokinin secretion. Stimulation of secretion by both agents was associated with an increase in cytosolic calcium and was inhibited by the calcium channel blocker, diltiazem (10 microM). The calcium-calmodulin kinase II inhibitor, KN-65 (1.4 microM), markedly reduced IBMX-stimulated secretion, but had no effect on phenylalanine-mediated activity. KN-62 also inhibited IBMX-induced increases in cytosolic calcium, suggesting that cAMP may activate diltiazem-sensitive calcium channels by a calmodulin-dependent process.
在STC - 1细胞(一种肠道分泌胆囊收缩素的细胞系)中研究了胆囊收缩素的释放情况。用氨基酸L - 苯丙氨酸(20 mM)或磷酸二酯酶抑制剂异丁基甲基黄嘌呤(IBMX,100 microM)对细胞进行15分钟孵育,可刺激胆囊收缩素分泌。两种试剂对分泌的刺激均与胞质钙增加有关,并被钙通道阻滞剂地尔硫䓬(10 microM)抑制。钙 - 钙调蛋白激酶II抑制剂KN - 65(1.4 microM)显著降低了IBMX刺激的分泌,但对苯丙氨酸介导的活性没有影响。KN - 62也抑制了IBMX诱导的胞质钙增加,表明环磷酸腺苷(cAMP)可能通过钙调蛋白依赖性过程激活对地尔硫䓬敏感的钙通道。